Unusual reaction to Rituximab with intra-vascular hemolysis, rhabdomyolysis, renal failure and bone marrow necrosis.
Ramamoorthy
S K
SK
Marangolo
M
M
Durrant
E
E
Akima
S
S
Gottlieb
D J
DJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology*; D001854:Bone Marrow Cells / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D051437:Renal Insufficiency / Q000139:chemically induced*; D012206:Rhabdomyolysis / Q000139:chemically induced*; D000069283:Rituximab; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000139:chemically induced
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab